Osteoporosis detection: Is bmd testing the future?

Nurse Practitioner

Volumn 32, Issue 6, 2007, Pages 20-27

  Olson, Ann F ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ADULT; AGE DISTRIBUTION; AGED; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; EARLY DIAGNOSIS; ECHOGRAPHY; EPIDEMIOLOGY; FEMALE; FORECASTING; HOSPITALIZATION; HUMAN; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NURSING ASSESSMENT; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; PRIMARY PREVENTION; REFERENCE VALUE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; STANDARD;

ABSORPTIOMETRY, PHOTON; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIAS (EPIDEMIOLOGY); BONE DENSITY; EARLY DIAGNOSIS; ESTRADIOL; FEMALE; FORECASTING; HUMANS; MASS SCREENING; MIDDLE AGED; NURSING ASSESSMENT; OSTEOPOROSIS, POSTMENOPAUSAL; PRACTICE GUIDELINES; PRIMARY PREVENTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 34447265471     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000275351.56698.56     Document Type: Article

References (38)

1. Siris ES, Ya-Tin C, Abbott TA. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108-1112.
2. Sayegh RA, Stubblefield PG. Bone metabolism and the perimenopause overview, risk factors, screening, and osteoporosis preventive measures. Obstet Gynecol Clin North Am. Sep 2002;29(3):495-510.
3. Bone health and osteoporosis: a report of the surgeon general. Rockville, MN: U.S. Department of Health and Human Services; 2004.
4. Rohr CI, Sarkar A, Barber KR, Clements JM. Prevalence of prevention and treatment modalities used in populations are risk of osteoporosis. JOAO. 2004;104(7):281-287.
5. LaCroix AZ, Buist DS, Brenneman SK, et al. Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial. Med Care. 2005;43(3):293-302.
6. Legislative issues brief: Issues in osteoporosis advocacy. Washington, DC: National Osteoporosis Foundation; 1999.
7. Doheny MO, Sedlak CA, Estok P, et al. DXA valuable for bone mineral density testing. Nurse Pract. 2003;28(11):44-49.
8. Borer K. Physical activity in the prevention and amelioration of osteoporosis in women: Interaction of mechanical, hormonal and dietary factors. Sports Med. 2005;35(9):779-830.
9. Mauck KF, Clarke BL. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006;81(5):662-672.
10. Bergstrom I, Freyschuss B, Landgren BM. Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int. 2005;16(7):823-828.
11. Moreira Kulak CA, Schussheim DH, McMahon DJ, et al. Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract. 2000;6(4):296-304.
12. Finkelstein JS, Lee M-LT, Sowers M, et al. Ethnic Variation in Bone Density in Premenopausal and Early Perimenopausal Women: Effects of Anthropometric and Lifestyle Factors. J Clin Endocrinol Metab. 2002;87(7):3057-3067.
13. Chapurlat RD, Gamero P, Sornay-Rendu E, Arlot ME, et al. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int. 2000;11(6):493-498.
14. Huijbregts PA. Osteoporosis: epidemiology, histology, bone remodeling, and classification. part I of a two-part series. JMMT. 2001;9(3):134-142.
15. Janssen JM, Bland R, Hewison M, et al. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. J Cell Biochem. 1999;75(3):528-537.
16. Majumdar S. Current technologies in the evaluation of bone architecture. Curr Osteoporos Rep. 2003;1(3):105-109.
17. Lenchik L, Leib ES, Hamdy RC, et al. Executive summary International Society for Clinical Densitometry position development conference Denver, Colorado July 20-22, 2001. J Clin Densitom. 2002;5 Suppl:S1-3.
18. Bonnick SL. Bone mass measurement techniques in clinical practice: methods, applications, and interpretation. TGR. 2005;21(1):30-41.
19. Fogelman I, Blake GM: Different Approaches to Bone Densitometry. J Nucl Med. 2000;41(12):2015-2025.
20. Clinician course syllabus and associated reading materials. ISCD Bone Densitometry Course; March, 2006; Minneapolis, MN.
21. Densitometry as a Diagnostic Tool for the Identification and Treatment of Osteoporosis in Women. Institute for Clinical Systems Improvement.
22. Assessment of bone mineral density and fracture risk. Vol 4: National Institute of Health: National Resource Center; April 2002.
23. Khan A, Bachrach L, Brown JP, et al. Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom. 2004;7(1):51-63.
24. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929-1936.
25. Looker AC, Orwoll ES, Johnston CC, Jr., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12(11):1761-1768.
26. Binkley N, Kiebzak GM, Lewiecki EM, et al. Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res. 2005;20(2):195-201.
27. Lewiecki EM, Watts NB, McClung MR, et al. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab. 2004;89(8):3651-3655.
28. Baim S. Basic science of bone densitometry and device operating principles. ISCD Bone Densitometry Course; March 11-12, 2006; Minneapolis, MN.
29. Baim S, Wilson CR, Lewiecki EM, et al. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom.2005;8(4):371-378.
30. Lewiecki EM, Binkley N, Bilezikian JP, et al. Official positions of the International Society for Clinical Densitometry. Osteoporos Int. 2006;17(11):1700-1701.
31. Leslie, Adler, El-Hajj F, et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J of Clin Densitom. 2006;9(1):22.
32. Adami S, Giannini S, Giorgino G, et al. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study. Calcif Tissue Int. 2004;74:317-321.
33. Physician's guide to prevention and treatment of osteoporosis: National Osteoporosis Foundation; 2003.
34. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.[erratum appears in Endocr Pract. 2004;10(1):90]. Endocr Pract. 2003;9(6):544-564.
35. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause. 2006;13(3):340-367.
36. ACR practice guideline for the performance of adult dual or single x-ray absorptiometry: American College of Radiology; 2006.
37. Khan AA, Brown JP, Kendler DL, et al. The 2002 Canadian bone densitometry recommendations: take-home messages. CMAJ. 2002;167(10):1141-1145.
38. Bray VJ. Osteoporosis screening guidelines. The International Society for Clinical Densitometry.